BAVIS_1170X120_10-19-20

AllianceRx Walgreens Prime

Kesimpta available through AllianceRx Walgreens Prime

Kesimpta available through AllianceRx Walgreens Prime

ORLANDO, Fla. —  Kesimpta (ofatumumab), the first and only self-administered, targeted B-cell therapy for patients with relapsing forms of multiple sclerosis (MS) in adults, is available through AllianceRx Walgreens Prime. MS is a rare disease of the central nervous system that affects nearly 1 million people in the United States, according to the National MS Society. MS disrupts the flow of information

AllianceRx Walgreens Prime cancer patients can manage care online with new digital tool

AllianceRx Walgreens Prime cancer patients can manage care online with new digital tool

ORLANDO, Fla. – Cancer patients who self-administer their therapy can now better manage their care online, thanks to the latest digital clinical assessment available only through AllianceRx Walgreens Prime. The newly-released self-serve tool simplifies patients’ online experiences when refilling their prescriptions. Earlier this year, AllianceRx Walgreens Prime announced the release of clinical assessments available for patients

AllianceRx Walgreens Prime named exclusive distributor for HRA Pharma Rare Diseases

AllianceRx Walgreens Prime named exclusive distributor for HRA Pharma Rare Diseases

ORLANDO — HRA Pharma Rare Diseases has named AllianceRx Walgreens Prime – one of the largest specialty and home delivery pharmacies in the United States – as the exclusive specialty pharmacy and clinical support provider for two of its rare disease drugs, Lysodren and Metopirone. Lysodren (mitotane) is the only FDA-approved drug to treat inoperable, functional or

AllianceRx Walgreens Prime offers digital clinical assessments

AllianceRx Walgreens Prime offers digital clinical assessments

ORLANDO, Fla. — Patients with chronic or complex conditions can better manage their care online, thanks to new digital clinical assessments available only through AllianceRx Walgreens Prime. In the wake of the global pandemic, the nation’s third largest specialty and home delivery pharmacy fast-tracked the release of these tools to simplify patients’ online experience when

Rick Miller receives NASP Distinguished Service Award

Rick Miller receives NASP Distinguished Service Award

ORLANDO, Fla. — The National Association of Specialty Pharmacy (NASP) has bestowed upon Rick Miller, vice president of clinical and professional services at AllianceRx Walgreens Prime, the Distinguished Service Award at the opening general session of its 2020 annual meeting. The Distinguished Service Award is given to the individual who has made a sustained contribution to

Inqovi now available through AllianceRx Walgreens Prime

Inqovi now available through AllianceRx Walgreens Prime

ORLANDO, Fla. — Adults with certain types of rare blood cancers can now receive their treatment in the comfort of their own home, thanks to a new medication available through a limited distribution with AllianceRx Walgreens Prime. Inqovi (decitabine and cedazuridine), manufactured by Taiho Oncology, treats adult patients with myelodysplastic syndromes (MDS) (a type of blood cancer) and

AllianceRx Walgreens Prime unveils new patented process for delivering specialty medicine

AllianceRx Walgreens Prime unveils new patented process for delivering specialty medicine

ORLANDO, Fla. — A new patented process for delivering specialty medicine will assure AllianceRx Walgreens Prime patients receive their medicine delivered at the correct temperature. AllianceRx Walgreens Prime, one of the nation’s largest specialty and home delivery pharmacies, will exclusively use the patent – held by parent company Walgreens – to help increase patient safety, improve patient

AllianceRx Walgreens Prime to distribute Vyepti

AllianceRx Walgreens Prime to distribute Vyepti

ORLANDO, Fla. — Lundbeck, a global pharmaceutical company specializing in brain diseases, has named AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute its newest medication for the preventive treatment of migraine in adults. The medication, Vyepti (eptinezumab-jjmr), is the first and only intravenous preventive treatment for migraine. Migraine is a complex and incapacitating neurological

AllianceRx Walgreens Prime studies the use of cyclin-dependent kinase 4/6 inhibitors in breast cancer patients

AllianceRx Walgreens Prime studies the use of cyclin-dependent kinase 4/6 inhibitors in breast cancer patients

ORLANDO, Fla. —A recent study of metastatic breast cancer (MBC) patients, prescribed a class of drugs that interrupt malignant cell growth, revealed high rates of adherence, low side effects and low rates of patients stopping their medication. The class of drugs is known as cyclin-dependent kinase (CDK) 4/6 inhibitors. The retrospective study was conducted by AllianceRx

AllianceRx Walgreens Prime renews sponsorship of web-based continuing education

AllianceRx Walgreens Prime renews sponsorship of web-based continuing education

ORLANDO, Fla. —  AllianceRx Walgreens Prime has renewed its sponsorship of accredited, web-based continuing education (CE) customized for members of the National Association of Specialty Pharmacy (NASP), which includes AllianceRx Walgreens Prime pharmacists. The CE content is accredited, managed and delivered through ProCE, a nationally recognized provider of CE for healthcare professionals. “We are proud to

AllianceRx Walgreens Prime presents study at NASP meeting

AllianceRx Walgreens Prime presents study at NASP meeting

ORLANDO, Fla. — AllianceRx Walgreens Prime announced results from a new study analyzing data from patients prescribed interleukin-17 (IL-17) inhibitors for psoriasis. Patients reported improvements in psoriatic symptoms and demonstrated increased medication adherence after switching to one of the three IL-17 medications included in the study. The study was conducted with Walgreens, a parent company of

AllianceRx Walgreens Prime adds LDDs

AllianceRx Walgreens Prime adds LDDs

ORLANDO, Fla. — AllianceRx Walgreens Prime has announced additional medicines available to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs (LDDs), these specialty medicines treat certain types of multiple sclerosis (MS), Lambert-Eaton myasthenic syndrome (LEMS) and a form of non-Hodgkin’s lymphoma (NHL), among other complex conditions. Since last spring, the

AllianceRx Walgreens Prime expands offerings

AllianceRx Walgreens Prime expands offerings

ORLANDO, Fla. — AllianceRx Walgreens Prime announced additional medicines available to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs (LDDs), these specialty medicines treat certain types of multiple sclerosis (MS), Lambert-Eaton myasthenic syndrome (LEMS) and a form of non-Hodgkin’s lymphoma (NHL), among other complex conditions. Since last spring, the following

AllianceRx Walgreens Prime sponsors web-based continuing education program

AllianceRx Walgreens Prime sponsors web-based continuing education program

ORLANDO, Fla. — AllianceRx Walgreens Prime is sponsoring accredited, web-based continuing education (CE) customized specifically for members of the National Association of Specialty Pharmacy (NASP), which includes AllianceRx Walgreens Prime pharmacists. The CE content is accredited, managed and delivered through ProCE, a nationally recognized provider of CE for healthcare professionals. As part of its ongoing professional development and

1 2 3